Eugenol Toxicity in Human Dental Pulp Fibroblasts of Primary Teeth

The aim of the study was to determine the eugenol concentrations at which toxicity occurs in human dental pulp fibroblasts of primary teeth. Study design: Samples of primary dental pulp tissue were taken. Tissue samples were seeded by means of explant technique and used in the 4th-5th pass. Single Cell Gel Electrophoresis (Comet), phenazine MeThoSulfate (MTS), LIVE/DEAD® Cell Viability/Toxicity and trypan blue assays for evaluation of the cytotoxicity of increasing concentrations of eugenol (0.06 to 810 μM) were performed. Results: The results of toxicity tests showed toxic effects on dental pulp fibroblasts, even at very low concentrations of eugenol (0.06 μM). Very low concentrations of eugenol produce high toxicity in human dental pulp fibroblasts. Conclusions: All of the concentrations of eugenol that we evaluated produced high toxicity in human dental pulp fibroblasts of primary teeth.

Toxicity, eugenol, fibroblasts.

1. Edwards V, Markovic E, Matisons J, Young F. Development of an in vitro reproductive screening assay for novel pharmaceutical compounds. Biotechnol Appl Biochem; 5: 163–171, 2008.

2. Tannure PN, Azevedo CP, Barcelos R, Gleiser R, Primo LG. Long-term outcomes of primary tooth pulpectomy with and without smear layer removal: a randomized split-mouth clinical trial. Pediatr Dent; 33: 316–320, 2011.

3. Lin B, Zhao Y, Yang J, Wang W, Ge LH. Effects of zinc oxide-eugenol and calcium hydroxide/ iodoform on delaying root resorption in primary molars without successors. Dent Mater J; 33: 471–475, 2014.

4. Hui-Derksen EK, Chen CF, Majewski R, Tootla RG, Boynton JR. Retrospective record review: reinforced zinc oxide-eugenol pulpotomy: a retrospective study. Pediatr Dent; 35: 43–46, 2013.

5. Markowitz K, Moynihan M, Liu M. Biologic properties of eugenol and zinc oxide-eugenol. Oral Surg Oral Med Oral Pathol; 73: 729–737, 1992.

6. Mutoh N, Tani-Ishii N. A biocompatible model for evaluation of the responses of rat periapical tissue to a new zinc oxide-eugenol sealer. Dent Mater J; 30: 176–182, 2011.

7. Vera J, Siqueira JF Jr, Ricucci D, Loghin S, Fernández N, Flores B, Cruz Ag. One- versus two-visit endodontic treatment of teeth with apical periodontitis: a histobacteriologic study. J Endod; 38: 1040–1052, 2012.

8. Bakkali F, Averbeck S, Averbeck D, Idaomar M. Biological effects of essential oils- a review. Food Chem Toxicol; 46: 446–475, 2008.

9. Devi KP, Sakthivel R, Nisha SA, Suganthy N, Pandian SK. Eugenol alters the integrity of cell membrane and acts against the nosocomial pathogen Proteus mirabilis. Arch Pharm Res; 36: 282–292, 2013.

10. Sipe HJ Jr, Lardinois OM, Mason RP. Free radical metabolism of methyleugenol and related compounds. Chem Res Toxicol; 27: 483–489, 2014.

11. Ding W, Levy DD, Bishop ME, Lyn-Cook Lascelles E, Kulkarni R, Chang CW, Aidoo A, Manjanatha MG. Methyleugenol genotoxicity in the Fischer 344 rat using the Comet assay and pathway-focused gene expression profiling. Toxicol Sci; 123: 103–112, 2011.

12. Zore GB, Thakre AD, Jadhav S, Karuppayil SM. Terpenoids inhibit Candida albicans growth by affecting membrane integrity and arrest of cell cycle. Phytomedicine; 18: 1181–1190, 2011.

13. Darvishi E, Omidi M, Bushehri AA, Golshani A, Smith ML. The antifungal eugenol perturbs dual aromatic and branched-chain amino acid permeases in the cytoplasmic membrane of yeast. PLoS One; 8: e76028, 2013.

14. Khan A, Ahmad A, Akhtar F, Yousuf S, Xess I, Khan LA, Manzoor N. Induction of oxidative stress as a possible mechanism of the antifungal action of three phenylpropanoids. FEMS Yeast Res; 11: 114–122, 2011.

15. Roberts SK, McAinsh M, Cantopher H, Sandison S. Calcium dependence of eugenol tolerance and toxicity in Saccharomyces cerevisiae. PLoS One; 9: e102712, 2014.

16. Raghavendra RH, Naidu KA. Spice active principles as the inhibitors of human platelet aggregation and thromboxane biosynthesis. Prostaglandins Leukot Essent Fatty Acids; 81: 73–78, 2009.

17. Bakopoulou A, Papadopoulos T, Garefis P. Molecular toxicology of substances released from resin-based dental restorative materials. Int J Mol Sci; 10: 3861–3899, 2009.

18. Slyskova J, Langie SA, Collins AR, Vodicka P. Functional evaluation of DNA repair in human biopsies and their relation to other cellular biomarkers. Front Genet; 5: 116, 2014.

19. Collins AR. The comet assay for DNA damage and repair: principles, applications, and limitations. Molecular Biotech; 26: 249–261, 2004.

20. Singh NP, McCoy MT, Tice RR, Schneider EL. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res; 175: 184–191, 1988.

21. Singh NP, Penn PE, Pendergrass WR, Wolf NS. White light-mediated DNA strand breaks in lens epithelial cells. Exp Eye Res; 75: 555–560, 2002.

22. Morandini AC, Sipert CR, Ramos-Junior ES, Brozoski DT, Santos CF. Periodontal ligament and gingival fibroblasts participate in the production of TGF-β, interleukin (IL)-8 and IL-10. Braz Oral Res; 25: 157–162, 2011.

23. Sipert C, Morandini A, Modena K, Dionísio T, Machado M, Oliveira S, Campanelli AP, Santos CF. CCL3 and CXCL12 production in vitro by dental pulp fibroblasts from permanent and deciduous teeth stimulated by Porphyromonas gingivalis LPS. J Appl Oral Sci; 21: 99–105, 2013.

24. Yilmaz Z, Dogan AL, Ozdemir O, Serper A. Evaluation of the cytotoxicity of different root canal sealers on L929 cell line by MTT assay. Dent Mater J; 31: 1028–1032, 2012.

25. Shih YH, Lin DJ, Chang KW, Hsia SM, Ko SY, Lee SY, Hsue SS, Wang TH, Chen YL, Shieh TM. Evaluation physical characteristics and comparison antimicrobial and anti-inflammation potentials of dental root canal sealers containing hinokitiol in vitro. PLoS One; 9: e94941, 2014.

26. Fujisawa S, Atsumi T, Kidoma H. Antioxidant and prooxidant action of eugenol-related compounds and their cytotoxicity. Toxicology; 177: 39–54, 2002.

27. Kwon J, Illeperuma R, Kim J, Kim K, Kim K. Cytotoxicity evaluation of zinc oxide-eugenol and non-eugenol cements using different fibroblast cell lines. Acta Odont Scand; 72: 64–70, 2013.

28. Correa GT, Veranio GA, Silva LE, Hirata Junior R, Coil JM, Scelza MF. Cytotoxicity evaluation of two root canal sealers and a commercial calcium hydroxide paste on THP1 cell line by trypan blue assay. J Appl Oral Sci; 17: 457–461, 2009.

29. Samara A, Sarri Y, Stravopodis D, Tzanetakis GN, Kontakiotis EG, Anastasiadou E. A comparative study of the effects of three root-end filling materials on proliferation and adherence of human periodontal ligament fibroblasts. J Endod; 37: 865–870, 2011.

30. Mutoh N, Satoh T, Watabe H, Tani-Ishii N. Evaluation of the biocompatibility of resin-based root canal sealers in rat periapical tissue. Dent Mater J; 32: 413–419, 2013.

31. Shen Q, Li W, Li W. The effect of clove oil on the transdermal delivery of Ibuprofen in the rabbit by in vitro and in vivo methods. Drug Dev Ind Pharm; 33: 1369–1374, 2007.

32. Silva EJ, Accorsi-Mendonça T, Almeida JF, Ferraz CC, Gomes BP, Zaia AA. Evaluation of cytotoxicity and up-regulation of gelatinases in human fibroblast cells by four root canal sealers. Int Endod J; 45: 49–56, 2012.

33. Goulet F, Vachon P, Hélie P. Evaluation of the toxicity of eugenol at anesthetic doses in African clawed frogs (Xenopus laevis). Toxicol Pathol; 39: 471–477, 2011.

34. Gardner I, Wakazono H, Bergin P, de Waziers I, Beaune P, Kenna JG, Caldwell J. Cytochrome P450 mediated bioactivation of methyleugenol to 1’-hydroxymethyleugenol in Fischer 344 rat and human liver microsomes. Carcinogenesis; 18: 1775–1783, 1997.

35. Jeurissen SM, Bogaards JJ, Boersma MG, ter Horst JP, Awad HM, Fiamegos YC, van Beek TA, Alink GM, Sudhölter EJ, Cnubben NH, Rietjens IM. Human cytochrome p450 enzymes of importance for the bioactivation of methyleugenol to the proximate carcinogen 1’-hydroxymethyleugenol. Chem Res Toxicol; 19: 111–116, 2006.

36. Jetten MJ, Claessen SM, Dejong CH, Lahoz A, Castell JV, van Delft JH, Kleinjans JC. Interindividual variation in response to xenobiotic exposure established in precision-cut human liver slices. Toxicology; 2: 61–69, 2014.

37. Wang S, Chen F, Tang L. IL-32 promotes breast cancer cell growth and invasiveness. Oncol Lett; 9: 305–307, 2015.

38. Liao TT, Wang L, Jia RW, Fu XH, Chua H. Lipophilic organic pollutants induce changes in phospholipid and membrane protein composition leading to Vero cell morphological change. J Environ Sci Health B; 49: 760–768, 2014.

39. Tsakalozou E, Adane ED, Liang Y, Arnold SM, Leggas M. Protracted dosing of the lipophilic camptothecin analogue AR-67 in non-small cell lung cancer xenografts and humans. Cancer Chemother Pharmacol; 74: 45–54, 2014.